Exhibit 99.3

	Emdeon Corporation
	Consolidated 2005 and 2006 Financial Guidance
Amounts in thousands, except per share information
	Three Months Ended				Year Ended				Year Ended
	December 31, 2005				December 31, 2005				December 31, 2006
	Range				Range				Range
Revenues	$	320,000	$	330,000	$	1,269,643	$	1,279,643	$	1,360,000	$	1,410,000
Income before taxes, non-cash and other items	$	48,500	$	52,500	$	181,482	$	185,482	$	220,000	$	250,000
Income per share before taxes, non-cash and other items	$	0.13	$	0.14	$	0.51	$	0.52	$	0.58	$	0.66
Taxes, non-cash and other items:
Depreciation and amortization		17,000		18,000		69,940		70,940		92,500		97,000
Non-cash advertising and stock-based compensation		5,000		6,000		15,486		16,486		13,000		15,000
Legal expense		—		—		14,347		14,347		—		—
Income tax provision		3,500		4,500		11,180		12,180		22,000		30,000
Other expense		—		—		7,407		7,407		—		—
Minority interest		700		800		700		800		2,500		3,000
Net income	$	22,300	$	23,200	$	62,422	$	63,322	$	90,000	$	105,000
Net income per common share	$	0.06	$	0.06	$	0.18	$	0.18	$	0.24	$	0.28
Weighted average shares		370,000		370,000		356,000		356,000		380,000		380,000

     Background and Assumptions

• Our guidance, for all periods, does not include any unannounced acquisitions that may occur, but does include the acquisition of Conceptis Technologies Inc. announced by WebMD Health on Tuesday, November 1, 2005, and expected to close in December 2005.

• Our guidance, for all projected periods, does not include any expenses related to the Department of Justice investigation.

• Our guidance, for all periods, does not reflect the impact of expensing stock options under SFAS 123(R).

• Our guidance, for all periods, does not reflect any potential repurchases of shares of our outstanding securities.